-
1
-
-
84947134818
-
-
Agency EM (2008) Volume 9A of The Rules Governing Medicinal Products in the European Union—Guidelines on Pharmacovigilance for Medicinal Products for Human Use
-
Agency EM (2008) Volume 9A of The Rules Governing Medicinal Products in the European Union—Guidelines on Pharmacovigilance for Medicinal Products for Human Use. http://ec.europa.eu/health/files/eudralex/vol-9/pdf/vol9a_09-2008_en.pdf
-
-
-
-
2
-
-
76949096462
-
Epidemiology and comorbidity of psoriasis in children
-
COI: 1:STN:280:DC%2BC3c3ksVegtQ%3D%3D, PID: 19922529
-
Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schaefer I (2010) Epidemiology and comorbidity of psoriasis in children. Br J Dermatol 162(3):633–636
-
(2010)
Br J Dermatol
, vol.162
, Issue.3
, pp. 633-636
-
-
Augustin, M.1
Glaeske, G.2
Radtke, M.A.3
Christophers, E.4
Reich, K.5
Schaefer, I.6
-
3
-
-
77950291474
-
Co-Morbidity and age-related prevalence of psoriasis—analysis of health insurance data in Germany
-
PID: 20169297
-
Augustin M, Reich K, Glaeske G, Schaefer I, Radtke M (2010) Co-Morbidity and age-related prevalence of psoriasis—analysis of health insurance data in Germany. Acta Derm Venereol 90(2):147–151
-
(2010)
Acta Derm Venereol
, vol.90
, Issue.2
, pp. 147-151
-
-
Augustin, M.1
Reich, K.2
Glaeske, G.3
Schaefer, I.4
Radtke, M.5
-
4
-
-
84892161996
-
German psoriasis registry PsoBest: objectives, methodology and baseline data
-
PID: 24393314
-
Augustin M, Spehr C, Radtke MA, Boehncke WH, Luger T, Mrowietz U, Reusch M, Strömer K, Wozel G, Kiedrowski RV, Rustenbach SJ, Purwins S, Reich K (2014) German psoriasis registry PsoBest: objectives, methodology and baseline data. J Dtsch Dermatol Ges 12(1):48–57
-
(2014)
J Dtsch Dermatol Ges
, vol.12
, Issue.1
, pp. 48-57
-
-
Augustin, M.1
Spehr, C.2
Radtke, M.A.3
Boehncke, W.H.4
Luger, T.5
Mrowietz, U.6
Reusch, M.7
Strömer, K.8
Wozel, G.9
Kiedrowski, R.V.10
Rustenbach, S.J.11
Purwins, S.12
Reich, K.13
-
5
-
-
84929630938
-
Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort
-
[Epub ahead of print]
-
Ahlehoff O, Skov L, Gislason G, Gniadecki R, Iversen L, Bryld LE, Lasthein S, Lindhardsen J, Kristensen SL, Torp-Pedersen C, Hansen PR (2014) Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort. J Eur Acad Dermatol Venereol. doi:10.1111/jdv.12768[Epub ahead of print]
-
(2014)
J Eur Acad Dermatol Venereol
-
-
Ahlehoff, O.1
Skov, L.2
Gislason, G.3
Gniadecki, R.4
Iversen, L.5
Bryld, L.E.6
Lasthein, S.7
Lindhardsen, J.8
Kristensen, S.L.9
Torp-Pedersen, C.10
Hansen, P.R.11
-
6
-
-
84874445437
-
Adalimumab: long-term safety in 23,458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn’s disease
-
COI: 1:CAS:528:DC%2BC3sXnt12rs74%3D
-
Burmester GR, Panaccione R, Gordon KB, McIlraith MJ, Lacerda AP (2013) Adalimumab: long-term safety in 23,458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn’s disease. Ann Rheum 72(4):517–524
-
(2013)
Ann Rheum
, vol.72
, Issue.4
, pp. 517-524
-
-
Burmester, G.R.1
Panaccione, R.2
Gordon, K.B.3
McIlraith, M.J.4
Lacerda, A.P.5
-
7
-
-
84919773683
-
Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008–2013 results of the Biobadaderm registry
-
COI: 1:STN:280:DC%2BC2crovVOguw%3D%3D, PID: 24684267
-
Carretero G, Ferrandiz C, Dauden E, Vanaclocha Sebastián F, Gómez-García FJ, Herrera-Ceballos E, De la Cueva-Dobao P, Belinchón I, Sánchez-Carazo JL, Alsina-Gibert M, López-Estebaranz JL, Ferrán M, Torrado R, Carrascosa JM, Carazo C, Rivera R, Jiménez-Puya R, García-Doval I, BIOBADADERM Study Group (2015) Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008–2013 results of the Biobadaderm registry. J Eur Acad Dermatol Venereol 29(1):156–163
-
(2015)
J Eur Acad Dermatol Venereol
, vol.29
, Issue.1
, pp. 156-163
-
-
Carretero, G.1
Ferrandiz, C.2
Dauden, E.3
Vanaclocha Sebastián, F.4
Gómez-García, F.J.5
Herrera-Ceballos, E.6
De la Cueva-Dobao, P.7
Belinchón, I.8
Sánchez-Carazo, J.L.9
Alsina-Gibert, M.10
López-Estebaranz, J.L.11
Ferrán, M.12
Torrado, R.13
Carrascosa, J.M.14
Carazo, C.15
Rivera, R.16
Jiménez-Puya, R.17
García-Doval, I.18
-
8
-
-
84947134819
-
-
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (2013) European Medicines Agency. Accessed 27 Mar 2013
-
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (2013) European Medicines Agency. http://www.encepp.eu. Accessed 27 Mar 2013
-
-
-
-
9
-
-
84883403500
-
Systemic psoriasis therapy shows high between-country variation: a sign of unwarranted variation? Cross-sectional analysis of baseline data from the PSONET registries
-
COI: 1:STN:280:DC%2BC3srhslyltQ%3D%3D, PID: 23551034
-
Garcia-Doval I, Rustenbach SJ, Stern R, Dam TN, Cohen AD, Baker C, Spuls PI, Naldi L, Network Psonet (2013) Systemic psoriasis therapy shows high between-country variation: a sign of unwarranted variation? Cross-sectional analysis of baseline data from the PSONET registries. Br J Dermatol 169(3):710–714
-
(2013)
Br J Dermatol
, vol.169
, Issue.3
, pp. 710-714
-
-
Garcia-Doval, I.1
Rustenbach, S.J.2
Stern, R.3
Dam, T.N.4
Cohen, A.D.5
Baker, C.6
Spuls, P.I.7
Naldi, L.8
Network, P.9
-
10
-
-
84947134820
-
-
Glicklich R, Dreyer N (2010) Registries for evaluating patient outcomes: a user’s guide. In: 2nd (edn) Agency for Healthcare Research and Quality (US), Rockville (MD)
-
Glicklich R, Dreyer N (2010) Registries for evaluating patient outcomes: a user’s guide. In: 2nd (edn) Agency for Healthcare Research and Quality (US), Rockville (MD). http://www.ncbi.nlm.nih.gov/books/NBK49444/pdf/TOC.pdf
-
-
-
-
11
-
-
39749089389
-
-
(ISPE) ISoP (2008) Guidelines for good pharmacoepidemiology practices (GPP). Pharmacoepidemiol Drug Saf 17:200–208
-
(ISPE) ISoP (2008) Guidelines for good pharmacoepidemiology practices (GPP). Pharmacoepidemiol Drug Saf 17:200–208
-
-
-
-
12
-
-
78649528986
-
Memorandum registry for health services research
-
Mueller D, Augustin M, Banik N, Baumann W, Bestehorn K, Kieschke J, Lefering R, Maier B, Mathis S, Rustenbach SJ, Sauerland S, Semler SC, Stausberg J, Sturm H, Unger C, Neugebauer EA (2010) Memorandum registry for health services research. Gesundheitswesen 72(11):824–839
-
(2010)
Gesundheitswesen
, vol.72
, Issue.11
, pp. 824-839
-
-
Mueller, D.1
Augustin, M.2
Banik, N.3
Baumann, W.4
Bestehorn, K.5
Kieschke, J.6
Lefering, R.7
Maier, B.8
Mathis, S.9
Rustenbach, S.J.10
Sauerland, S.11
Semler, S.C.12
Stausberg, J.13
Sturm, H.14
Unger, C.15
Neugebauer, E.A.16
-
13
-
-
84857904170
-
German S3—Guidelines on the Treatment of Psoriasis Vulgaris (Short Version)
-
COI: 1:CAS:528:DC%2BC38XivFOrsL8%3D, PID: 22350179
-
Nast A, Boehncke WH, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Sammain A, Schlaeger M, Sebastian M, Sterry W, Streit V, Augustin M, Erdmann R, Klaus J, Koza J, Mueller S, Orzechowski HD, Rosumeck S, Schmid-Ott G, Weberschock T, Rzany B (2012) German S3—Guidelines on the Treatment of Psoriasis Vulgaris (Short Version). Arch Dermatol Res 304(2):87–113
-
(2012)
Arch Dermatol Res
, vol.304
, Issue.2
, pp. 87-113
-
-
Nast, A.1
Boehncke, W.H.2
Mrowietz, U.3
Ockenfels, H.M.4
Philipp, S.5
Reich, K.6
Rosenbach, T.7
Sammain, A.8
Schlaeger, M.9
Sebastian, M.10
Sterry, W.11
Streit, V.12
Augustin, M.13
Erdmann, R.14
Klaus, J.15
Koza, J.16
Mueller, S.17
Orzechowski, H.D.18
Rosumeck, S.19
Schmid-Ott, G.20
Weberschock, T.21
Rzany, B.22
more..
-
14
-
-
84863781790
-
Challenges for synthesising data in a network of registries for systemic psoriasis therapies
-
COI: 1:STN:280:DC%2BC38npvF2nsw%3D%3D, PID: 22678413
-
Ormerod AD, Augustin M, Baker C, Chosidow O, Cohen AD, Dam TN, Garcia-Doval I, Lecluse LL, Schmitt-Egenolf M, Spuls PI, Watson KD, Naldi L (2012) Challenges for synthesising data in a network of registries for systemic psoriasis therapies. Dermatology 224(3):236–243
-
(2012)
Dermatology
, vol.224
, Issue.3
, pp. 236-243
-
-
Ormerod, A.D.1
Augustin, M.2
Baker, C.3
Chosidow, O.4
Cohen, A.D.5
Dam, T.N.6
Garcia-Doval, I.7
Lecluse, L.L.8
Schmitt-Egenolf, M.9
Spuls, P.I.10
Watson, K.D.11
Naldi, L.12
-
15
-
-
84868611859
-
PSOLAR: design, utility, and preliminary results of a prospective, international, disease based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents
-
COI: 1:CAS:528:DC%2BC38Xhs1Kmt7nN, PID: 23134986
-
Papp KA, Strober B, Augustin M, Calabro S, Londhe A, Chevrier M, PSOLAR investigators and Steering Committee (2012) PSOLAR: design, utility, and preliminary results of a prospective, international, disease based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents. J Drugs Dermatol 11(10):1210–1217
-
(2012)
J Drugs Dermatol
, vol.11
, Issue.10
, pp. 1210-1217
-
-
Papp, K.A.1
Strober, B.2
Augustin, M.3
Calabro, S.4
Londhe, A.5
Chevrier, M.6
-
16
-
-
70249137988
-
European S3-guidelines on the systemic treatment of psoriasis vulgaris
-
PID: 19712190
-
Pathirana D, Ormerod AD, Saiag P, Smith C, Spuls PI, Nast A, Barker J, Bos JD, Burmester GR, Chimenti S, Dubertret L, Eberlein B, Erdmann R, Ferguson J, Girolomoni G, Gisondi P, Giunta A, Griffiths C, Hönigsmann H, Hussain M, Jobling R, Karvonen SL, Kemeny L, Kopp I, Leonardi C, Maccarone M, Menter A, Mrowietz U, Naldi L, Nijsten T, Ortonne JP, Orzechowski HD, Rantanen T, Reich K, Reytan N, Richards H, Thio HB, van de Kerkhof P, Rzany B (2009) European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 23(Suppl 2):1–70. doi:10.1111/j.1468-3083.2009.03389.x
-
(2009)
J Eur Acad Dermatol Venereol
, vol.23
, pp. 1-70
-
-
Pathirana, D.1
Ormerod, A.D.2
Saiag, P.3
Smith, C.4
Spuls, P.I.5
Nast, A.6
Barker, J.7
Bos, J.D.8
Burmester, G.R.9
Chimenti, S.10
Dubertret, L.11
Eberlein, B.12
Erdmann, R.13
Ferguson, J.14
Girolomoni, G.15
Gisondi, P.16
Giunta, A.17
Griffiths, C.18
Hönigsmann, H.19
Hussain, M.20
Jobling, R.21
Karvonen, S.L.22
Kemeny, L.23
Kopp, I.24
Leonardi, C.25
Maccarone, M.26
Menter, A.27
Mrowietz, U.28
Naldi, L.29
Nijsten, T.30
Ortonne, J.P.31
Orzechowski, H.D.32
Rantanen, T.33
Reich, K.34
Reytan, N.35
Richards, H.36
Thio, H.B.37
van de Kerkhof, P.38
Rzany, B.39
more..
-
17
-
-
84947134822
-
-
PsoNet. European Registry of Psoriasis [Internet]. Centro Studi GISED. Available via internet. Accessed 27 Mar 2013
-
PsoNet. European Registry of Psoriasis [Internet]. Centro Studi GISED. Available via internet. http://www.psonet.eu/cms/public/files/psonet-protocol.pdf. Accessed 27 Mar 2013
-
-
-
-
18
-
-
33751542934
-
Psoriasis therapy in real life: the need for registries
-
PID: 17135739
-
Schmitt-Egenolf M (2006) Psoriasis therapy in real life: the need for registries. Dermatology 213:327–330
-
(2006)
Dermatology
, vol.213
, pp. 327-330
-
-
Schmitt-Egenolf, M.1
-
19
-
-
0035089120
-
The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients
-
COI: 1:STN:280:DC%2BD3M7lvVahsQ%3D%3D, PID: 11171678
-
Zink A, Listing J, Klindworth C, Zeidler H, German Collaborative Arthritis Centres (2001) The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients. Ann Rheum Dis 60(3):199–206
-
(2001)
Ann Rheum Dis
, vol.60
, Issue.3
, pp. 199-206
-
-
Zink, A.1
Listing, J.2
Klindworth, C.3
Zeidler, H.4
|